Loading viewer...
investor_presentation
Format: PDF investor_presentation
Jay Mazelsky President and Chief Executive Officer March 7, 2022IDEXX Laboratories, Inc. Raymond James 43rdAnnual Institutional Investors Conference
President and Chief Executive Officer
March 7, 2022IDEXX Laboratories, Inc.
Raymond James 43rdAnnual
Institutional Investors Conference2 © 2022 IDEXX Laboratories, Inc. All rights reserved.Safe Harbor Disclaimer
The following information contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. These forward-looking
statements are based on management ’s current expectations and beliefs, as well as a number of assumptions concerning future events. These statements are
subject to risks, uncertainties, assumptions and other important factors. You are cautioned not to put undue reliance on such forward -looking statements because
actual results may vary materially from those expressed or implied. The reports filed by the Company pursuant to United States securities laws contain discussions
of some of these risks and uncertainties. The Company assumes no obligation to, and expressly disclaims any obligation to, updat e or revise any forward-looking
statements, whether as a result of new information, future events or otherwise. You are advised to review the Company ’s filings with the United States Securities
and Exchange Commission (which are available from the SEC ’s EDGAR database at www.sec.gov and via the Company ’s website at www.idexx.com ).
We refer in this presentation to projections communicated at our Investor Day on August 12, 2021 and our 2022 outlook communi cated on February 2, 2022; these
references speak only as of the respective dates on which they were communicated and shall not be deemed to be a reiteration or affirmation of the guidance or an
indication that our expectations have not changed since that time.
Non-GAAP Financial Measures
In this presentation, we refer to some non-GAAP financial measures. For a reconciliation to the most comparable GAAP financial measures, we refer you to our
footnotes and the Appendix to this presentation, which also refer to the Company's Annual Report on Form 10-K for the year ended December 31, 2021, both
available at www.idexx.com/investors .
Please refer to additional footnotes in the Appendix.
3 © 2022 IDEXX Laboratories, Inc. All rights reserved.
IDEXX Focus: Increasing Companion Animal Healthcare Globally Through
Innovation, Insight and Customer -focused Engagement
Decades+ opportunity to increase
standard of care (~$37 billion TAM)
Innovation delivering best -in-class,
integrated diagnostic and software solutions
Global commercial capability and multi-modality offering advancing adoption
and diagnostic utilization
Long- term, durable 10%+ organic
growth potential with high ROIC4 © 2022 IDEXX Laboratories, Inc. All rights reserved.
Preview truncated — download the full document for the complete content.
investor_presentation
96 Pages
IDEXX Laboratories Investor Presentation 2023 | Raymond James Conference
conferenceconference
31 Pages
investor_presentation
23 Pages
Stryve Foods, Inc.
Adani Energy Solutions Investor Presentation January 2026
investor_presentationinvestor_presentation
41 Pages
Adani Energy Solutions Limited